title: The use of long-acting contraceptives in adolescents.
abstract: DMPA and implants have played an important role in the attempt to prevent teenage pregnancies. Adolescent health care providers should provide continued counseling to girls using DMPA or implants and should promptly address any concern associated with these methods. Future studies are warranted to explore ways to prevent or reduce the side effects of DMPA and implants, as well as to develop new, optimal, long-acting contraceptives. Detailed baseline information should be obtained in every future study that explores the presence of side effects during the use of long-acting contraceptives.
authors.affiliation: Division of Adolescent Medicine, Hasbro Children's Hospital, Providence, Rhode Island, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Harel
authors.forename: B
authors.initials: B
authors.lastname: Cromer
mesh_terms: D000293:Adolescent; D003271:Contraceptive Agents, Female / Q000009:adverse effects / Q000627:therapeutic use*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000009:adverse effects / Q000627:therapeutic use*; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D045167:Progesterone Congeners / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D003280:Contraceptives, Oral, Synthetic; D003692:Delayed-Action Preparations; D045167:Progesterone Congeners; D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate